N-[1-(4-cyclopropyl-1,2,3-thiadiazol-5-yl)ethyl]ethene-1-sulfonamide
Structure Info
- Chemspace ID
- CSSB21332081763 (In-Stock Building Blocks)
- IUPAC Name
- N-[1-(4-cyclopropyl-1,2,3-thiadiazol-5-yl)ethyl]ethene-1-sulfonamide
- Mol formula
- C9H13N3O2S2
- Mol weight
- 259 Da
- Catalog Number(s)
- BBLS21332081763, EN300-54825779, bbls21332081763
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.19
- Heavy atoms count
- 16
- Rotatable bond count
- 4
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.555
- Polar surface area (Å)
- 72
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 1
![Chemical structure of N-[1-(4-cyclopropyl-1,2,3-thiadiazol-5-yl)ethyl]ethene-1-sulfonamide (C9H13N3O2S2) - CSSB21332081763](/st/structure/200/3c5073e9674d9883d1f3d71b27185e8b/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DC%2528N%253DNS1%2529C1CC1.png "C9H13N3O2S2")
- Zoom the structure
- CSSB21332081763
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 996.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 1,043.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 1,090.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 1,137.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 1,185.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 2,324.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 3,438.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 5,099.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-[1-(4-methyl-1,2,3-thiadiazol-5-yl)ethyl]ethene-1-sulfonamide - CSSB00155117894](/st/structure/200/bca4f3dc520dbda2df67b2594cbcb850/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DC%2528C%2529N%253DNS1.png)
![Chemical structure of N-[(4-cyclopropyl-1,2,3-thiadiazol-5-yl)methyl]ethene-1-sulfonamide - CSSB03548232987](/st/structure/200/c1f5cba729d490a8436b287551873024/C%253DCS%2528%253DO%2529%2528%253DO%2529NCC1%253DC%2528N%253DNS1%2529C1CC1.png)
![Chemical structure of N-[1-(4-propyl-1,2,3-thiadiazol-5-yl)ethyl]ethene-1-sulfonamide - CSSB06835390660](/st/structure/200/1b99604c0ebf59b8b41191fb5a7faefa/CCCc1nnsc1C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-[1-(4-cyclopropyl-1,2,3-thiadiazol-5-yl)ethyl]prop-2-enamide - CSSB21332042356](/st/structure/200/1909f25ba102b04f61251caa8e61efdc/CC%2528NC%2528%253DO%2529C%253DC%2529C1%253DC%2528N%253DNS1%2529C1CC1.png)
![Chemical structure of N-[(4-cyclobutyl-1,2,3-thiadiazol-5-yl)methyl]ethene-1-sulfonamide - CSSB03443467184](/st/structure/200/4a057cdf14265ff62139cd2da0e9b15b/C%253DCS%2528%253DO%2529%2528%253DO%2529NCC1%253DC%2528N%253DNS1%2529C1CCC1.png)
![Chemical structure of N-[1-(5-methyl-1,3,4-thiadiazol-2-yl)ethyl]ethene-1-sulfonamide - CSSB00155118312](/st/structure/200/38a19127fe97273164b737ccf517a084/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNN%253DC%2528C%2529S1.png)
![Chemical structure of N-[1-(2,4-dichloro-1,3-thiazol-5-yl)ethyl]ethene-1-sulfonamide - CSSB21332109042](/st/structure/200/ae8f230d56e347434be5e259106d9d68/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DC%2528Cl%2529N%253DC%2528Cl%2529S1.png)
